Bone Disorders
An Introduction to Bone Disorders
Osteoporosis medications aim to markedly reduce the occurrence of fractures but can have rare and serious adverse effects. The introduction of new drug classes, including an anti-sclerostin monoclonal antibody and a parathyroid hormone-related peptide analogue, into the treatment landscape, offers new options to patients. The potential for cell-based therapies and drugs that target the elimination of senescent cells in the bone microenvironment are currently being investigated.
Browse our gallery of video highlights and short articles from the conference hub, providing the latest expert insights from major conferences and peer-reviewed articles from the journal portfolio.
Our supporting partners do not constitute an endorsement of the content on this page.
Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.
What if your medical degree could launch more than a clinical career? In this candid and compelling read, Dr Jon Edelson shares his lessons for early-career clinicians ready to think beyond the bedside and explore the business of medicine.
Rare diseases can present numerous challenges for those living with these conditions and the healthcare professionals caring for them. In this interview we discuss some of these with Lisa Sarfaty, VP of Communication and Engagement for NORD (The National Organization ...
Our society partner, NORD (The National Organization for Rare Disorder) has planned several initiatives to support this year’s Rare Disease Day on 28 February. These activities are aimed at raising awareness about rare diseases and the challenges faced by people ...
It was a pleasure to talk with Dr. Andrea R Genazzani (International Society of Gynecological Endocrinology and European Society of Gynecology) to find out when, in whom and for how long hormone replacement therapy should be administered for bone loss ...
touchENDOCRINOLOGY were delighted to catch up with Dr. Andrea R. Genazzani (International Society of Gynecological Endocrinology and European Society of Gynecology) to discuss the health burden of osteoporosis in post-menopausal women and how HRT could be used as a prevention ...
We were delighted to talk with Dr Michael R. McClung (Oregon Osteoporosis Center, Portland, OR, USA) around the current unmet needs and standard of care for osteoporosis and the therapeutic targets currently being investigated that could lead to new drug ...
Dr Richard Keen (Director, Centre for Metabolic Bone Disease, Royal National Orthopaedic Hospital, Stanmore, UK) joins us for Rare Disease Day to discuss the spectrum of rare bone disorders, the challenges of diagnosis, and the impact on patient quality of ...
Ethan Crough, a middle school technology education teacher, joins us for Rare Disease Day to celebrate diversity as a man living with achondroplasia. Ethan discusses his experiences of living with achondroplasia and highlights useful resources such as Little People of ...
touchIMMUNOLOGY joins Professor Nicola Veronese (University of Padova, Italy) at WCO21 to discuss the efficacy, safety and quality of pharma-grade chondroitin sulfate in osteoarthritis treatment. Questions 1. What is the rationale for the use of highly purified chondroitin sulfate (hpCS) in ...
touchIMMUNOLOGY joins Professor Neil Gittoes (University of Birmingham, UK), Chair of the Royal Osteoporosis Society, at WCO21 to discuss the mission of the society and hopes for the current initiatives to forward osteoporosis research. Questions 1. Could you tell us a ...
Renal tubular acidosis (RTA) is characterized by the impaired ability of the kidneys to absorb filtered bicarbonate or to excrete titrable acid in urine.1Â It manifests as normal anion gap (hyperchloremic) metabolic acidosis. RTA may be of four types: type 1 (...
Osteoporosis is a major health issue, affecting around 200 million women worldwide. Although osteoporosis is typically associated with women, it is also diagnosed in men; one in three women over age 50 will experience osteoporotic fractures, as will one in five men ...
As the population ages, the need to promote good musculoskeletal health throughout the lifecourse increases. Physical activity and adequate nutrition are known to be beneficial to bone and muscle at all ages; individually the benefits of physical activity and inadequate ...
Disorders related to bone health are commonly seen in clinical practice in India. The most common conditions are vitamin D deficiency-related disorders (rickets, osteomalacia), followed by osteoporosis, hyperparathyroidism, endocrine osteopathies, and impaired bone health associated with systemic diseases.1–3 Vitamin ...
Diabetes mellitus has been associated with decreased bone quality and higher risk of fractures in several studies.1–3 Patients with type 1 diabetes have lower bone mineral density and patients with type 2 diabetes have an increased risk of fracture despite normal ...
Log into your Touch Account
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Sign up with an Email
Or use a .
This Functionality is for
Members Only
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
